纤溶酶荧光底物D-VLK-AMC

产品价格面议

产品品牌AAT Bioquest

最小起订≥1 5mg

供货总量5 5mg

发货期限自买家付款之日起 7 天内发货

浏览次数28

更新日期2024-03-01 09:55

诚信档案

西安百萤生物科技有限公司

+ 加为商友发送信件当前离线

会员级别：企业会员

已缴纳：0.00 元保证金

我的勋章： [诚信档案]

在线客服：

企业二维码： 企业名称加二维码西安百萤生物科技有限公司

进入店铺公司介绍公司地址产品信息

企业名片在线询价

企业名片

西安百萤生物科技有限公司

联系人：第五晓东(先生)

联系固话：029-68064558

联系地址：西安市高新区草堂科技产业基地秦岭大道西6号科技企业加速器二区9幢2单元20401号房

【友情提示】：来电请说明在商易网看到我们的，谢谢！

商品信息

基本参数

品牌：	AAT Bioquest
所在地：	陕西西安市
起订：	≥1 5mg
供货总量：	5 5mg
有效期至：	长期有效
储存条件：：	-15℃避光防潮
保质期：：	12个月
规格：	5mg

详细说明

产品参数

Ex (nm)	341	Em (nm)	441
分子量	743.69	溶剂	DMSO
存储条件	在零下15度以下保存, 避免光照

产品概述

产品基本信息

产品名称：纤溶酶荧光底物D-VLK-AMC

储存条件：-15℃避光防潮

保质期：12个月

产品物理化学光谱特性

分子量：743.68

溶剂：DMSO

Ex(nm):351

Em(nm):430

产品介绍

纤溶酶荧光底物D-VLK-AMC是美国AAT Bioquest生产的荧光底物，D-VLK-AMC是纤溶酶,是一种敏感、高度特异性荧光底物。它可以与荧光显微镜，荧光微孔板或流式细胞仪一起使用。百萤生物是AAT Bioquest的中国代理商，为您提供优质的纤溶酶荧光底物D-VLK-AMC。

试剂应用文献

Diabetogenic agent alloxan is a proteasome inhibitor
Authors: Wenjuan Zhou, Lingling Wei, Ting Xiao, Chunyou Lai, Min Peng, Lingli Xu, Xiangwei Luo, Shaoping Deng, Fengxue Zhang
Journal: Biochemical and Biophysical Research Communications (2017): 400--406

Delineation of molecular pathways involved in cardiomyopathies caused by troponin T mutations
Authors: Jennifer E Gilda, Xianyin Lai, Frank A Witzmann, Aldrin V Gomes
Journal: Molecular & Cellular Proteomics (2016): 1962--1981

Diclofenac induces proteasome and mitochondrial dysfunction in murine cardiomyocytes and hearts
Authors: Rajeshwary Ghosh, Sumanta K Goswami, Luis Felipe BB Feitoza, Bruce Hammock, Aldrin V Gomes
Journal: International Journal of Cardiology (2016): 923--935

Advanced-glycation-end-product-induced formation of immunoproteasomes: involvement of RAGE and Jak2/STAT1
Authors: Stefanie Grimm, Christiane Ott, Melanie Hörlacher, Daniela Weber, Annika Höhn, Tilman Grune
Journal: Biochemical Journal (2012): 127--139

参考文献

Alveolar extracellular 20S proteasome in patients with acute respiratory distress syndrome
Authors: Sixt SU, Adamzik M, Spyrka D, Saul B, Hakenbeck J, Wohlschlaeger J, Costabel U, Kloss A, Giesebrecht J, Dahlmann B, Peters J.
Journal: Am J Respir Crit Care Med (2009): 1098

Quinone reductase acts as a redox switch of the 20S yeast proteasome
Authors: Sollner S, Schober M, Wagner A, Prem A, Lorkova L, Palfey BA, Groll M, Macheroux P.
Journal: EMBO Rep (2009): 65

Comparative expression analysis and characterization of 20S proteasomes in human intestinal tissues: The proteasome pattern as diagnostic tool for IBD patients
Authors: Visekruna A, Joeris T, Schmidt N, Lawrenz M, Ritz JP, Buhr HJ, Steinhoff U.
Journal: Inflamm Bowel Dis (2009): 526

Enzymatic properties of the 20S proteasome in wheat endosperm and its biochemical characteristics after seed imbibition
Authors: Shi C, Rui Q, Xu LL.
Journal: Plant Biol (Stuttg) (2009): 849

BCL-2 family regulation by the 20S proteasome inhibitor bortezomib
Authors: Fennell DA, Chacko A, Mutti L.
Journal: Oncogene (2008): 1189

Toward a full characterization of the human 20S proteasome subunits and their isoforms by a combination of proteomic approaches
Authors: Uttenweiler-Joseph S, Claverol S, Sylvius L, Bousquet-Dubouch MP, Burlet-Schiltz O, Monsarrat B.
Journal: Methods Mol Biol (2008): 111

Circulating 20S proteasome levels in patients with mixed connective tissue disease and systemic lupus erythematosus
Authors: Majetschak M, Perez M, Sorell LT, Lam J, Maldonado ME, Hoffman RW.
Journal: Clin Vaccine Immunol (2008): 1489

The 20S proteasome of Schistosoma mansoni: a proteomic analysis
Authors: Castro-Borges W, Cartwright J, Ashton PD, Braschi S, Guerra Sa R, Rodrigues V, Wilson RA, Curwen RS.
Journal: Proteomics (2007): 1065

Design and synthesis of a novel class of furan-based molecules as potential 20S proteasome inhibitors
Authors: Fu Y, Xu B, Zou X, Ma C, Yang X, Mou K, Fu G, Lu Y, Xu P.
Journal: Bioorg Med Chem Lett (2007): 1102

beta-Subunit appendages promote 20S proteasome assembly by overcoming an Ump1-dependent checkpoint
Authors: Li X, Kusmierczyk AR, Wong P, Emili A, Hochstrasser M.
Journal: Embo J (2007): 2339